Talphera (TLPH) Deferred Taxes (2010 - 2018)
Talphera (TLPH) posted Deferred Taxes of $74000.0 for Q4 2018, up 384.62% on a QoQ basis from -$26000.0 in Q3 2018, and down 84.55% year-over-year from $479000.0 in Q4 2017.
Analysis
Talphera (TLPH) Deferred Taxes (2010 - 2018) Analysis & Trends
Talphera has reported Deferred Taxes for 9 years, with the latest figure at $74000.0 in Q4 2018.
- On a quarterly basis, Deferred Taxes fell 84.55% year-over-year to $74000.0 in Q4 2018; TTM through Dec 2018 was $113000.0, a 83.93% decrease from a year earlier, with the FY2019 full-year figure at -$352000.0, down 411.5% from the prior year.
- Deferred Taxes was $74000.0 for Q4 2018 at Talphera, up from -$26000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $479000.0 in Q4 2017, with the low at -$196000.0 in Q4 2015.
- Average Deferred Taxes over 5 years is $16210.5, with a median of -$29000.0 recorded in 2014.
- The sharpest annual moves came in 2015 and 2017: Deferred Taxes slumped 1407.69% in 2015, then soared 1003.77% in 2017.
- Over 5 years, Deferred Taxes stood at -$13000.0 in 2014, then plunged by 1407.69% to -$196000.0 in 2015, then soared by 72.96% to -$53000.0 in 2016, then jumped by 1003.77% to $479000.0 in 2017, then tumbled by 84.55% to $74000.0 in 2018.
- The last three Deferred Taxes figures came in at $74000.0 (Q4 2018), -$26000.0 (Q3 2018), and -$119000.0 (Q2 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | -291.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -587.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -69.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 194.40 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -27.60 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 74,000.00 |
| Sep 30, 2018 | -26,000.00 |
| Jun 30, 2018 | -119,000.00 |
| Mar 31, 2018 | 184,000.00 |
| Dec 31, 2017 | 479,000.00 |
| Sep 30, 2017 | 267,000.00 |
| Mar 31, 2017 | -43,000.00 |
| Dec 31, 2016 | -53,000.00 |
| Sep 30, 2016 | -52,000.00 |
| Jun 30, 2016 | -49,000.00 |
| Mar 31, 2016 | -48,000.00 |
| Dec 31, 2015 | -196,000.00 |
| Sep 30, 2015 | -38,000.00 |
| Jun 30, 2015 | -37,000.00 |
| Mar 31, 2015 | -13,000.00 |
| Dec 31, 2014 | -13,000.00 |
| Sep 30, 2014 | 11,000.00 |
| Jun 30, 2014 | 9,000.00 |
| Mar 31, 2014 | -29,000.00 |
| Dec 31, 2013 | -29,000.00 |